EP
ALXN

Edgestream Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

Edgestream Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,544
Closed -$467K – 597
2021
Q2 		$467K Buy
+2,544
New +$437K 0.03% 361
2021
Q1 		– Sell
-9,419
Closed -$1.47M – 462
2020
Q4 		$1.47M Buy
+9,419
New +$1.21M 0.07% 263
2018
Q3 		– Sell
-20,130
Closed -$2.5M – 354
2018
Q2 		$2.5M Buy
+20,130
New +$2.35M 0.51% 66

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Edgestream Partners's ALXN Position: Q3 2021 in Review

Edgestream Partners sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,544 shares — an estimated $467K sold.

Edgestream Partners first reported a position in ALXN in Q2 2018 and held it in 3 quarters. The position peaked at $2.5M in Q2 2018. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Edgestream Partners reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Edgestream Partners sold 2,544 Alexion Pharmaceuticals shares in Q3 2021, an estimated $467K.
  • Edgestream Partners first reported a position in Alexion Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Edgestream Partners's Alexion Pharmaceuticals position peaked at $2.5M in Q2 2018.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Edgestream Partners's 13F filing for Q3 2021, filed 15 Nov 2021.